Breaking News Instant updates and real-time market news.

AVEO

Aveo Pharmaceuticals

$2.07

-0.46 (-18.18%)

14:46
11/06/18
11/06
14:46
11/06/18
14:46

Aveo Pharmaceuticals downgraded to Neutral from Buy at National Securities

  • 27

    Nov

AVEO Aveo Pharmaceuticals
$2.07

-0.46 (-18.18%)

10/01/18
PIPR
10/01/18
NO CHANGE
Target $5
PIPR
Overweight
Piper remains confident in Aveo reporting positive TIVO-3 data
After an Independent Steering Committee recommended the initiation of top-line analysis of Aveo Pharmaceuticals' Phase 3 TIVO-3 trial of tivozanib in third-line renal cell carcinoma, Piper Jaffray analyst Edward Tenthoff noted that the lower than expected event rate of 242 events "minimally reduces" powering of the trial to 88% from the originally planned for 90%, but he remains confident in positive top-line TIVO-3 data being reported in about 6 weeks. Tenthoff reiterates his Overweight rating and $5 price target on Aveo shares.
10/22/18
PIPR
10/22/18
NO CHANGE
Target $5
PIPR
Overweight
TiNivo data competitively position Aveo Pharmaceuticals, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff believes the data for tivozanib combined with Opdivo to treat metastatic renal cell carcinoma presented at the ESMO meeting competitively position Aveo Pharmaceuticals as the treatment landscape for front-line RCC moves to I-O and TKI combinations. An ORR of 56% and DCR of 96% represent "promising early activity," said Tenthoff., who reiterates his Overweight rating and $5 target on Aveo shares.
11/05/18
PIPR
11/05/18
NO CHANGE
Target $5
PIPR
Overweight
Aveo Pharmaceuticals tivozanib's initial sales seen at $27M, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff kept his Overweight rating and $5 price target on Aveo Pharmaceuticals after its announcement this evening that the phase 3 TIVO-3 trial of tivozanib vs. Nexavar in 3rd line renal cell carcinoma met its primary endpoint target. The analyst expects the company to file a New Drug Application for tivozanib in the next 6 months, and after its expected approval, he estimates that the initial 2020 sales will be around $27M before reaching about $189M in 2025. Tenthoff adds that based on the data, there is further opportunity for tivozanib use in compbination with Opdivo.
11/06/18
HCWC
11/06/18
NO CHANGE
Target $9
HCWC
Buy
Aveo Pharmaceuticals price target raised to $9 from $6.50 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Aveo Pharmaceuticals to $9 saying the company announced positive topline results from the Phase 3 TIVO-3 study investigating the use of tivozanib for the treatment of refractory renal cell carcinoma. The analyst views the results as "very promising" and believes tivozanib still has "ample opportunity" to show a superior overall survival benefit. He believes the drug is on track for approval in 2020 and keeps a Buy rating on Aveo Pharmaceuticals.

TODAY'S FREE FLY STORIES

NAK

Northern Dynasty

$0.69

0.024 (3.59%)

13:41
11/16/18
11/16
13:41
11/16/18
13:41
Upgrade
Northern Dynasty rating change  »

Northern Dynasty upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$26.78

0.03 (0.11%)

13:40
11/16/18
11/16
13:40
11/16/18
13:40
Options
Size strangle in SPDR Financials »

Size strangle in SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:35
11/16/18
11/16
13:35
11/16/18
13:35
General news
Fedspeak will be very limited next week »

Fedspeak will be very…

LVS

Las Vegas Sands

$53.63

-0.11 (-0.20%)

13:25
11/16/18
11/16
13:25
11/16/18
13:25
Options
Las Vegas Sands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTWS

Connecticut Water

$69.67

-0.08 (-0.11%)

, SJW

SJW Corp.

$64.12

-0.32 (-0.50%)

13:25
11/16/18
11/16
13:25
11/16/18
13:25
Conference/Events
Connecticut Water to host special shareholder meeting »

Special Shareholder…

CTWS

Connecticut Water

$69.67

-0.08 (-0.11%)

SJW

SJW Corp.

$64.12

-0.32 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

GOOG

Alphabet

$1,060.06

-4.68 (-0.44%)

, GOOGL

Alphabet Class A

$1,064.87

-6.35 (-0.59%)

13:18
11/16/18
11/16
13:18
11/16/18
13:18
Periodicals
Diane Greene confirms Thomas Kurian to become Google Cloud CEO »

Diane Greene, the CEO of…

GOOG

Alphabet

$1,060.06

-4.68 (-0.44%)

GOOGL

Alphabet Class A

$1,064.87

-6.35 (-0.59%)

ORCL

Oracle

$51.20

0.56 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 05

    Dec

  • 06

    Dec

  • 03

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/16/18
11/16
13:17
11/16/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/16/18
11/16
13:16
11/16/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$273.80

0.96 (0.35%)

13:12
11/16/18
11/16
13:12
11/16/18
13:12
Periodicals
White House says Trump just expressing optimism on trade, CNBC reports »

CNBC's Eamon Javers…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$273.80

0.96 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$273.79

0.95 (0.35%)

13:10
11/16/18
11/16
13:10
11/16/18
13:10
Periodicals
White House tells CNBC not to read too much into Trump's trade comments »

Immediately following…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$273.79

0.95 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:09
11/16/18
11/16
13:09
11/16/18
13:09
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 11/16…

BHGE

Baker Hughes

$23.40

0.11 (0.47%)

13:05
11/16/18
11/16
13:05
11/16/18
13:05
Hot Stocks
Baker Hughes reports U.S. rig count up 1 to 1,082 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 14

    Nov

ECA

Encana

$7.56

-0.19 (-2.45%)

13:05
11/16/18
11/16
13:05
11/16/18
13:05
Options
Encana call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYRS

Syros Pharmaceuticals

$8.03

0.16 (2.03%)

13:00
11/16/18
11/16
13:00
11/16/18
13:00
Recommendations
Syros Pharmaceuticals analyst commentary  »

Syros Phase I dose…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$273.77

0.93 (0.34%)

12:54
11/16/18
11/16
12:54
11/16/18
12:54
General news
Trump says China 'wants to make a deal' on trade »

President Trump said in…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$273.77

0.93 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$85.27

-1.48 (-1.71%)

12:50
11/16/18
11/16
12:50
11/16/18
12:50
Options
Notable call writing in Paypal as shares drop 2% »

Notable call writing in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 18

    Dec

GOOG

Alphabet

$1,051.92

-12.82 (-1.20%)

, GOOGL

Alphabet Class A

$1,057.14

-14.08 (-1.31%)

12:49
11/16/18
11/16
12:49
11/16/18
12:49
Periodicals
Google Cloud CEO to be replaced by former Oracle executive, CNBC reports »

Google (GOOG, GOOGL)…

GOOG

Alphabet

$1,051.92

-12.82 (-1.20%)

GOOGL

Alphabet Class A

$1,057.14

-14.08 (-1.31%)

ORCL

Oracle

$51.16

0.52 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 05

    Dec

  • 06

    Dec

  • 03

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$272.08

-0.76 (-0.28%)

12:45
11/16/18
11/16
12:45
11/16/18
12:45
General news
Markets bounce higher after Trump comments on China trade talks »

The markets moved higher…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$272.08

-0.76 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
11/16/18
11/16
12:45
11/16/18
12:45
General news
Breaking General news story  »

Week of 11/16…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$272.55

-0.29 (-0.11%)

12:40
11/16/18
11/16
12:40
11/16/18
12:40
General news
Breaking General news story on S&P 500, SPDR S&P 500 ETF Trust »

Trump says would like to…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$272.55

-0.29 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$272.55

-0.29 (-0.11%)

12:40
11/16/18
11/16
12:40
11/16/18
12:40
General news
Breaking General news story on S&P 500, SPDR S&P 500 ETF Trust »

Trump says does not want…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$272.55

-0.29 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$20.54

-0.53 (-2.52%)

12:40
11/16/18
11/16
12:40
11/16/18
12:40
Options
4K Jun 22.5 calls on iQiyi trade $3.40 »

4K Jun 22.5 calls on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$138.09

-5.77 (-4.01%)

12:38
11/16/18
11/16
12:38
11/16/18
12:38
Hot Stocks
Definers says not hired by Facebook for opposition research »

Definers Public Affairs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

LYB

LyondellBasell

$94.38

0.95 (1.02%)

, BAK

Braskem

$27.66

0.56 (2.07%)

12:30
11/16/18
11/16
12:30
11/16/18
12:30
Periodicals
LyondellBasell close to presenting binding offer for Braskem, Reuters says »

LyondellBasell (LYB) is…

LYB

LyondellBasell

$94.38

0.95 (1.02%)

BAK

Braskem

$27.66

0.56 (2.07%)

PBR

Petrobras

$14.87

0.32 (2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSH

Cognizant

$68.91

0.24 (0.35%)

12:30
11/16/18
11/16
12:30
11/16/18
12:30
Options
Call buying in Cognizant Tech as the company hosts an Investor Day Friday »

Call buying in Cognizant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 26

    Nov

  • 02

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.